CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX.
Jia W, Ren C, Wang L, Zhu B, Jia W, Gao M, Zeng F, Zeng L, Xia X, Zhang X, Fu T, Li S, Du C, Jiang X, Chen Y, Tan W, Zhao Z, Liu W.
Jia W, et al.
Oncotarget. 2016 Aug 23;7(34):55328-55342. doi: 10.18632/oncotarget.10530.
Oncotarget. 2016.
PMID: 27419372
Free PMC article.